Annamaria Offidani Selected Research

Annamaria Offidani Research Topics

Disease

45	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 01/2015
21	Hidradenitis Suppurativa 05/2024 - 03/2017
19	Infections 01/2023 - 03/2013
15	Neoplasms (Cancer) 03/2024 - 11/2002
14	Melanoma (Melanoma, Malignant) 08/2023 - 11/2002
11	Skin Diseases (Skin Disease) 05/2023 - 02/2018
10	Hyperhidrosis 11/2023 - 01/2003
9	Wounds and Injuries (Trauma) 11/2021 - 01/2008
8	Atopic Dermatitis (Atopic Eczema) 05/2023 - 01/2021
8	COVID-19 04/2022 - 11/2020
6	Inflammation (Inflammations) 05/2023 - 03/2015
6	Wound Infection (Wound Infections) 10/2021 - 01/2008
5	Skin Neoplasms (Skin Cancer) 05/2023 - 12/2019
5	Hypersensitivity (Allergy) 12/2022 - 03/2021
4	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2015
4	Cutaneous Malignant Melanoma 01/2023 - 06/2015
4	Burns 07/2022 - 01/2012
4	Surgical Wound 07/2022 - 04/2008
4	Actinic Keratosis 11/2021 - 01/2016
4	Sepsis (Septicemia) 09/2019 - 01/2016
3	Obesity 04/2024 - 07/2015
3	Psoriatic Arthritis 09/2023 - 01/2018
3	Pigmented Nevus (Melanocytic Nevus) 01/2023 - 11/2002
3	Chronic Urticaria 04/2021 - 01/2021
3	Cicatrix (Scar) 03/2021 - 01/2017
3	Nevus (Nevi) 01/2018 - 11/2002
3	Necrosis 09/2016 - 11/2014
3	Staphylococcal Infections 01/2016 - 06/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 11/2021
2	Atherosclerosis 01/2023 - 07/2015
2	Pain (Aches) 11/2022 - 01/2022
2	Bronchiolitis Obliterans Syndrome 09/2022 - 06/2021
2	Fibrosis (Cirrhosis) 09/2022 - 03/2015
2	Eczema 02/2022 - 07/2021
2	Squamous Cell Carcinoma of Head and Neck 10/2021 - 06/2021
2	Mycosis Fungoides 07/2021 - 01/2016
2	Keloid 01/2021 - 09/2010
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2021 - 09/2010
2	Urticaria (Hives) 01/2021 - 01/2021
2	Ulcerative Colitis 09/2020 - 01/2018
2	Oral Lichen Planus 02/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2015
12	Adalimumab (Humira)FDA Link 10/2022 - 03/2016
10	secukinumabIBA 03/2024 - 01/2017
9	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 06/2008
8	Nicotinamide N-MethyltransferaseIBA 03/2024 - 01/2018
7	Interleukin-17 (Interleukin 17)IBA 04/2024 - 06/2015
7	EnzymesIBA 03/2024 - 01/2018
7	CytokinesIBA 01/2023 - 01/2017
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 11/2002
6	Botulinum Toxins (Botulinum Toxin)IBA 11/2023 - 01/2003
5	InterleukinsIBA 04/2024 - 03/2016
5	N-nitroso-N-methyltyramine (NNMT)IBA 03/2024 - 01/2018
5	dupilumabIBA 01/2023 - 06/2021
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 07/2015
5	Infliximab (Remicade)FDA Link 02/2022 - 01/2016
5	Etanercept (Enbrel)FDA Link 02/2022 - 09/2016
5	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2003
5	Tigecycline (Tygacil)FDA Link 01/2018 - 01/2012
4	VaccinesIBA 08/2023 - 04/2021
4	Monoclonal AntibodiesIBA 01/2023 - 01/2017
4	dalbavancinIBA 11/2022 - 01/2020
4	Aryldialkylphosphatase (Paraoxonase)IBA 11/2021 - 01/2020
4	Interleukin-23 (Interleukin 23)IBA 04/2021 - 06/2015
4	TeicoplaninIBA 12/2016 - 01/2008
3	bimekizumabIBA 04/2024 - 01/2023
3	Messenger RNA (mRNA)IBA 03/2024 - 10/2020
3	AdipokinesIBA 01/2023 - 07/2015
3	oxybutynin (Tavor)FDA LinkGeneric 01/2023 - 03/2015
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022 - 09/2019
3	Daptomycin FDA Link 07/2022 - 12/2016
3	Ustekinumab (CNTO 1275)FDA Link 02/2022 - 01/2017
3	ixekizumabIBA 09/2021 - 01/2017
3	Omalizumab (Xolair)FDA Link 04/2021 - 01/2021
3	AllantoinIBA 01/2021 - 09/2010
3	SteroidsIBA 06/2020 - 01/2014
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2013 - 11/2002
2	RetinoidsIBA 05/2024 - 09/2019
2	MicroRNAs (MicroRNA)IBA 06/2023 - 05/2023
2	Antimicrobial PeptidesIBA 12/2022 - 01/2018
2	Biosimilar PharmaceuticalsIBA 10/2022 - 01/2020
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 03/2015
2	apremilastIBA 11/2021 - 01/2021
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2021 - 01/2021
2	Dacarbazine (DIC)FDA LinkGeneric 11/2021 - 12/2020
2	CollagenIBA 10/2021 - 06/2013
2	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2021 - 08/2020
2	Interleukin-12 (IL 12)IBA 04/2021 - 01/2017
2	calcipotriene (calcipotriol)FDA LinkGeneric 01/2021 - 06/2020
2	NeurotoxinsIBA 01/2021 - 03/2017
2	Antirheumatic Agents (DMARD)IBA 04/2020 - 11/2019
2	AntioxidantsIBA 01/2020 - 01/2019
2	golimumab FDA Link 11/2019 - 01/2019

Therapy/Procedure

41	Therapeutics 03/2024 - 06/2008
11	Biological Therapy 10/2022 - 01/2017
3	Aftercare (After-Treatment) 11/2021 - 01/2003
3	Phototherapy (Light Therapy) 01/2021 - 11/2010
2	Immunomodulation 04/2022 - 11/2020
2	Contraindications 07/2021 - 04/2021
2	Immunotherapy 06/2020 - 01/2018